Elevance Health Inc (ELV) is undervalued and we do not publish a verdict for Oscar Health Inc (OSCR).
We publish an intrinsic value for ELV but not for OSCR, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $602.54; the price of $402.43 is 33% below that value, and 80% of that value comes from beyond year five.
Leak Score 61/100 on 10 of 12 signals
We do not publish a value for this company: we do not know how much cash it holds.
Leak Score 59/100 on 3 of 12 signals
| Metric | ELV | OSCR |
|---|---|---|
| Verdict | Undervalued | Not valued |
| Price | $402.43 | $30.67 |
| Intrinsic value | $602.54 | — |
| Margin of safety | +33% | — |
| Leak Score | 61/100 (10/12) | 59/100 (3/12) |
| Market cap | $87.3B | $9.5B |
| Revenue growth, 5 years | 10.3% | 90.8% |
| Operating margin | 3.6% | 4.1% |
| Net margin | 2.5% | 3.6% |
| Return on equity | 11.2% | 34.3% |
| Debt to equity | 0.69 | 0.21 |
| P/E | 17.9x | 22.4x |
| Forward P/E | 13.6x | 13.1x |
| P/B | 1.9x | 4.6x |
| Dividend yield | 1.7% | — |